Company Overview and News

20
Walt Disney Stock Gets Some Good News but Needs a Lot More

3h investorplace
It’s been a good couple of months for Walt Disney (NYSE:DIS). Some good if not quite Earth-shattering news has come the company’s way. And Disney stock has risen about 11% since the beginning of June.
FOX CHTR CMCSA NFLX FOXA DIS ATVI

30
Don't Bet Against These High Yielding Food And Beverage Giants

2018-07-16 seekingalpha
I'm not sure that tangible book value is the best metric with which to value these sorts of businesses.
FB BUD GEC GE GOOG BRK.A CHTR BF.B GOOGL KHC GNE AHBIF DEO

25
Don't Bet Against These High Yielding Food & Beverage Giants

2018-07-16 seekingalpha
I'm not sure that tangible book value is the best metric with which to value these sorts of businesses.
BRK.A CHTR BUD GEC GE BF.B KHC GNE AHBIF DEO

22
Short Selling Ideas For July: Ugly Blue-Chip Balance Sheets

2018-07-13 seekingalpha
Total liabilities vs. current cash flows are getting to unsustainable levels for many brand name companies.
CHTR BUD GEC GE CMCSA TWX KHC GNE AHBIF TWC

12
Black Bear Value Partners Q2 Letter - ABX Shorts And Long Ideas + Changing Your Mind And Bayesian Inference

2018-07-13 seekingalpha
"The greatest shortcoming of the human race is our inability to understand the exponential function." -Albert Bartlett
LBRDB LSXMB BATRK FWONB AAL LSXMA BATRR LBRDK FWONA VA AN CHTR FWONK BATRB LSXMK LBRDA DAL BATRA TIVO

34
Is the Justice Department Ready for Prime Time This Time? - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CHTR DISH CCV.CL CCV CMCSA TWX CCZ CVS TWC AET CMCSK DIS

0
OverWatchID Accelerates Growth With New Denver Office

2018-07-12 globenewswire
Denver, July 12, 2018 (GLOBE NEWSWIRE) -- OverWatchID, a Denver-based market leader in cloud-based converged identity security solutions, has opened a new office in Denver to accommodate rapid growth and leverage the area’s diverse high-technology talent pool. Located at 900 S. Broadway, the new office space quintupled the office footprint and supports the company’s growth strategy.
CHTR

115
Oakmark Equity And Income Fund: Second Quarter 2018

2018-07-11 seekingalpha
The Equity and Income Fund earned 0.2% in the quarter, while the Lipper Balanced Fund Index, the Fund’s performance benchmark, gained 1.1%.
PM C.WSA DOV.WI NOV TEL CVS FNF BAC C.WS.B CHTR APY.WI GM.WS.A FNFV C.WS.A GM.WS.B GM.WS.C C.PRP DOV C.PRU GM ORCL C.PRS LBRDB BAC C C.PRL AAL C.PRJ C.PRK BHGE COMM MA ARNC C.PRG TWC LBRDK C.PRC BHI C.PRPCL CGBBW OCLCF JLL LBRDA FL APY GM.WSB UNH

37
Oakmark Global Fund: Second Quarter 2018

2018-07-11 seekingalpha
The Oakmark Global Fund’s three-month return declined 0.3%, compared to a 1.7% return for the MSCI World Index during the period and the Lipper Global Fund Index’s gain of 0.4%.
DGLD LBTY NOV UAA TEL GOOG IPG CS CHTR UGLD LBTYK LILAB GM.WS.A GM.WS.B GM.WS.C GM LUV CNHI LBRDB DSLV VIIX CSSLF VIIZ LBTYB MA LBTYA ARNC DDAIF RB LBRDK UA CSGKF GOOGL LILAK ZIV RBGLY LBRDA USLV TVIX GM.WSB THC TV XIV LILA

0
CHTR / Charter Communications, Inc. 8-K (Current Report)

2018-07-11 sec.gov
Document SECURITIES AND EXCHANGE COMMISSION
CHTR

0
CHTR / Charter Communications, Inc. 8-K (Current Report)

2018-07-11 sec.gov
Document SECURITIES AND EXCHANGE COMMISSION
CHTR

0
CHTR / Charter Communications, Inc. 8-K (Current Report)

2018-07-11 sec.gov
Document SECURITIES AND EXCHANGE COMMISSION
CHTR

33
What to Expect From Sun Valley’s ‘Summer Camp for Billionaires’ - Bloomberg

2018-07-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CCV TWX NFLX CCZ LNKD VZA CHTR VIAB AAPL AVGO CMCSK DIS CBS VIA LGF CBS.A CMCSA TWC CBS.WD BRK.A CCV.CL VZ LGF.A LGF.B CPV BRCM QCOM

1
CHTR / Charter Communications, Inc. / D. E. SHAW & CO, L.P. - SC 13G/A (Passive Investment)

2018-07-10 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CHTR

0
CHTR / Charter Communications, Inc. / D. E. SHAW & CO, L.P. - SC 13G/A (Passive Investment)

2018-07-10 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CHTR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to CHTR / Charter Communications, Inc. on message board site Silicon Investor.

Charter Communications (CHTR) Charter Communications (CHTR)
Richtree- Marche Movenpick of North America
CUSIP: 16119P108